$UHS

UHS: Q2 2026 net income rose to $358.4M on 8.3% higher revenues; 2026 outlook revised downward

Universal Health Services (UHS) reported Q2 2026 net income of $358.4M, up year over year, with revenues 8.3% higher. The company said adjusted EBITDA margin stayed strong, but operating cash flow fell. UHS revised its 2026 outlook slightly lower for EBITDA and EPS, citing risks from government reimbursement and interest rates.

Original reporting
Published Jul 27, 2026, 9:54 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 28, 2026, 4:10 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
UHS: Q2 2026 net income rose to $358.4M on 8.3% higher revenues; 2026 outlook revised downward — source image
Decision brief

The 30-second read

$UHSBearishMed
01

Why it matters

Traders may reprice expectations for 2026 profitability (EBITDA and EPS) and assess whether operating cash flow weakness reflects structural issues or timing effects, with reimbursement and interest rates flagged as risks.

02

Market read

A guidance reset for 2026 profitability metrics is the key actionable element, with cash flow and reimbursement/rate risks reinforcing caution.

03

What to watch

The summary does not quantify the magnitude of the EBITDA/EPS outlook reduction or cash flow drivers, so the market reaction may hinge on details not included here.

Relevance 7/10Novelty 6/10Timing: after-hours/filing update from the Jul. 28, 2026 8-K

Background

The text is a brief summary of a Universal Health Services 8-K, highlighting Q2 results and a revised 2026 outlook.

Company-level read

Ticker impact

$UHSBearishMedium confidence
Context

Universal Health Services reported Q2 2026 net income of $358.4M and 8.3% higher revenues, while revising 2026 EBITDA and EPS outlook downward.

Expected impact

Bias toward downside or multiple compression versus prior expectations, especially if the market was positioned for stable EBITDA/EPS.

Evidence & confidence

Downward guidance revision and declining operating cash flow are typically negative for near-term valuation, even with revenue and net income growth.

Market effects

Signals ongoing pressure points for healthcare providers tied to government reimbursement dynamics and interest-rate sensitivity.

No specific regional impact stated.

Primarily US healthcare reimbursement and rates exposure; limited global spillover implied.

Counterpoint

Revenue and net income grew year-over-year and adjusted EBITDA margin stayed strong, which could offset the guidance cut if cash flow decline is viewed as temporary.

Key entities

  • Universal Health Services, Inc.

    Reported Q2 2026 net income and revenues, noted cash flow decline, and revised 2026 EBITDA and EPS outlook downward.

Related articles

$UHSMed

UHS Cuts 2026 Profit Outlook Despite Revenue Growth

Universal Health Services (UHS) reported Q2 revenue up 8.3% to $4.64B and net income attributable to UHS of $358.4M ($5.98/share). Despite growth, it cut the 2026 adjusted EPS and adjusted EBITDA outlook midpoints by 2.6% and 1.9%, citing changing Medicaid reimbursements and operating trends. It also reported first-half revenue up 8.9% to $9.13B.

$UHSMed

5 Revealing Analyst Questions From Universal Health Services’s Q2 Earnings Call

Universal Health Services reported Q2 2026 revenue of $4.64B, up 8.3% year over year and slightly above estimates ($4.59B). Adjusted EPS was $5.98, near expectations, while adjusted EBITDA was $684M. Full-year adjusted EPS guidance midpoint was $22.97, below estimates, and EBITDA guidance midpoint was $2.66B. Management discussed acute care volume moderation, bed ramp-up, Talkspace integration, and Medicaid supplemental payment uncertainty.

$UHSMed

Hospitals See Massive Surge in Uninsured Patients After GOP’s Healthcare Cuts

Hospitals in the US report a rise in uninsured patients after enhanced ACA subsidies were not extended, according to The New York Times and Healthcare Dive. Universal Health Services (UHS) said losses from treating uninsured patients are higher than expected, and HCA Healthcare projected a $400 million revenue hit tied partly to more uninsured patients. SSM Health CEO cited patients unable to pay emergency bills.

$UHSMed

Questions about regulatory authority stall proposed overhaul of GW medical practice group

George Washington University’s Medical Faculty Associates (MFA) faces a stalled takeover as a jurisdiction dispute delays regulatory review. MFA, treating 4,600+ patients daily with over $400 million debt, would be acquired by Universal Health Services (UHS), with most doctors becoming UHS employees. D.C. AG Brian Schwalb ordered submission of documents by Sept. 30; parties dispute his authority.

$KOMed

Stocks making the biggest moves premarket: Coca-Cola, Sherwin-Williams, Johnson & Johnson & more

Premarket movers included Coca-Cola, Sherwin-Williams, Hilton, Johnson & Johnson, Corning, Cadence Design Systems, Rambus, Universal Health Services, Welltower, Happen (formerly LendingClub), and Cincinnati Financial. Key catalysts were earnings beats or misses and guidance changes, including J&J’s $5.5 billion talc settlement and Coca-Cola’s raised outlook after EPS and revenue topped estimates.